Your browser doesn't support javascript.
loading
Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy.
Mei, Heng; Chen, Fangping; Han, Yue; Hou, Ming; Huang, He; Huang, Xiaojun; Li, Yuhua; Liang, Aibin; Liu, Qifa; Niu, Ting; Peng, Jun; Qian, Wenbin; Song, Yongping; Wang, Jianxiang; Wang, Ying; Wu, Depei; Xu, Kailin; Yang, Linhua; Yang, Renchi; Zhang, Lei; Zhang, Liansheng; Zhang, Xi; Zhang, Xiaohui; Zhao, Weili; Han, Weidong; Hu, Yu.
Afiliação
  • Mei H; Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.
  • Chen F; Department of Hematology, Xiangya Third Hospital, Central South University, Changsha, Hunan 410013, China.
  • Han Y; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
  • Hou M; Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250063, China.
  • Huang H; Institute of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China.
  • Huang X; Peking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China.
  • Li Y; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, China.
  • Liang A; Department of Hematology, Tongji Hospital of Tongji University, Shanghai 200092, China.
  • Liu Q; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
  • Niu T; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
  • Peng J; Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250063, China.
  • Qian W; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China.
  • Song Y; Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan 450008, China.
  • Wang J; State Key Laboratory of Experimental Hematology and National Clinical Research Center for Blood Disease, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
  • Wang Y; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221006, China.
  • Wu D; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
  • Xu K; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221006, China.
  • Yang L; Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
  • Yang R; State Key Laboratory of Experimental Hematology and National Clinical Research Center for Blood Disease, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
  • Zhang L; State Key Laboratory of Experimental Hematology and National Clinical Research Center for Blood Disease, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
  • Zhang L; Department of Hematology, Lanzhou University Second Hospital, Lanzhou, Gansu 730030, China.
  • Zhang X; Medical Center of Hematology, Xinqiao Hospital, The Third Military Medical University, Chongqing 400037, China.
  • Zhang X; Peking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China.
  • Zhao W; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Han W; Molecular and Immunological Department, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
  • Hu Y; Bio-Therapeutic Department, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
Chin Med J (Engl) ; 135(14): 1639-1641, 2022 07 20.
Article em En | MEDLINE | ID: mdl-35984103
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Transtornos da Coagulação Sanguínea / Receptores de Antígenos Quiméricos Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Chin Med J (Engl) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Transtornos da Coagulação Sanguínea / Receptores de Antígenos Quiméricos Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Chin Med J (Engl) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China